Guillermo E Umpierrez Selected Research

Sodium

1/2023	Efficacy and safety of sotagliflozin in patients with type 2 diabetes and stage 3 chronic kidney disease.
1/2022	Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results.
12/2021	Efficacy and safety of sotagliflozin in patients with type 2 diabetes and severe renal impairment.
6/2016	AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY POSITION STATEMENT ON THE ASSOCIATION OF SGLT-2 INHIBITORS AND DIABETIC KETOACIDOSIS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guillermo E Umpierrez Research Topics

Disease

84	Type 2 Diabetes Mellitus (MODY) 03/2024 - 03/2006
79	Hyperglycemia 02/2024 - 03/2002
72	Hypoglycemia (Reactive Hypoglycemia) 02/2024 - 09/2004
22	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 10/2023 - 11/2002
21	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2023 - 04/2003
20	Critical Illness (Critically Ill) 01/2024 - 09/2007
15	Ketosis 01/2022 - 03/2004
11	Insulin Resistance 05/2024 - 03/2006
9	Hypertension (High Blood Pressure) 12/2023 - 07/2007
9	Obesity 05/2023 - 01/2013
9	Diabetes Mellitus 05/2023 - 07/2004
8	Chronic Renal Insufficiency 12/2023 - 10/2020
7	Infections 01/2024 - 08/2004
7	COVID-19 10/2023 - 07/2020
6	Prediabetic State (Prediabetes) 05/2023 - 01/2018
5	Body Weight (Weight, Body) 01/2023 - 03/2013
5	Inflammation (Inflammations) 01/2019 - 07/2012
4	Weight Loss (Weight Reduction) 05/2023 - 01/2021
4	Acidosis 02/2023 - 01/2003
4	Renal Insufficiency (Renal Failure) 01/2023 - 10/2018
4	Weight Gain 01/2023 - 10/2018
4	Wounds and Injuries (Trauma) 10/2021 - 01/2003
4	Acute Kidney Injury (Acute Renal Failure) 01/2017 - 04/2010
3	Chronic Kidney Failure (Chronic Renal Failure) 12/2023 - 01/2020
3	Cardiovascular Diseases (Cardiovascular Disease) 05/2023 - 11/2011
3	Albuminuria 01/2023 - 01/2019
3	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 01/2019
3	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 10/2021 - 01/2016
3	Diabetes Complications 06/2020 - 01/2017
3	Wound Infection (Wound Infections) 04/2017 - 04/2010
2	Myocardial Infarction 10/2023 - 01/2023
2	Dyslipidemias (Dyslipidemia) 05/2023 - 10/2022
2	Overweight 05/2023 - 01/2022
2	Heart Failure 01/2023 - 09/2014
2	Neoplasms (Cancer) 10/2022 - 01/2013
2	Vomiting 01/2019 - 08/2014
2	Major Depressive Disorder (Major Depressive Disorders) 01/2019 - 01/2016
2	Nausea 01/2019 - 08/2014
2	Bacteremia 04/2017 - 02/2011

Drug/Important Bio-Agent (IBA)

102	Insulin (Novolin)FDA Link 03/2024 - 01/2003
71	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 03/2002
43	Blood Glucose (Blood Sugar)IBA 02/2024 - 03/2002
19	Hypoglycemic Agents (Hypoglycemics)IBA 12/2023 - 08/2004
14	Insulin Glargine (Lantus)FDA Link 01/2022 - 07/2009
11	Hemoglobins (Hemoglobin)IBA 12/2023 - 09/2012
10	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 12/2023 - 01/2015
10	Sitagliptin Phosphate (Januvia)FDA Link 01/2021 - 03/2013
8	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 03/2013
6	AlbuminsIBA 12/2023 - 04/2010
6	IncretinsIBA 01/2019 - 07/2013
6	Nonesterified Fatty Acids (NEFA)IBA 08/2017 - 08/2004
5	Sodium-Glucose Transporter 2 InhibitorsIBA 05/2024 - 06/2016
5	CreatinineIBA 12/2023 - 11/2022
5	Glucagon-Like Peptide-1 ReceptorIBA 01/2023 - 08/2014
4	Dipeptidyl-Peptidase IV InhibitorsIBA 05/2024 - 01/2018
4	finerenoneIBA 12/2023 - 01/2022
4	SodiumIBA 01/2023 - 06/2016
4	LipidsIBA 01/2022 - 06/2012
4	C-Reactive ProteinIBA 01/2019 - 08/2004
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 05/2024 - 03/2015
3	KetonesIBA 02/2023 - 01/2003
3	Short-Acting InsulinIBA 01/2023 - 05/2008
3	Allopurinol (Remid)FDA LinkGeneric 11/2022 - 01/2019
3	Uric Acid (Urate)IBA 11/2022 - 01/2019
3	Bicarbonates (Hydrogen Carbonate)IBA 01/2021 - 09/2004
3	InsulinsIBA 06/2020 - 02/2009
3	LinagliptinIBA 11/2019 - 01/2018
3	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2019 - 09/2014
3	phospholipid emulsion soybean oil (Intralipid)IBA 03/2010 - 05/2007
3	CytokinesIBA 05/2008 - 03/2004
2	(2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA 01/2023 - 12/2021
2	Mineralocorticoid Receptor AntagonistsIBA 11/2022 - 01/2022
2	GlucocorticoidsIBA 01/2022 - 01/2021
2	Liraglutide FDA Link 01/2021 - 02/2016
2	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2020 - 08/2004
2	Hormones (Hormone)IBA 10/2020 - 09/2014
2	Growth Hormone (Somatotropin)IBA 10/2020 - 08/2004
2	CarbohydratesIBA 01/2020 - 02/2013
2	Pioglitazone (Actos)FDA Link 01/2020 - 03/2013
2	lixisenatideIBA 11/2019 - 01/2017
2	ThiazolidinedionesIBA 01/2018 - 03/2013
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 08/2017 - 04/2012
2	ElectrolytesIBA 03/2016 - 01/2003
2	dulaglutideIBA 03/2015 - 08/2014
2	2,4-thiazolidinedione (thiazolidinedione)IBA 03/2013 - 12/2009

Therapy/Procedure

63	Therapeutics 01/2024 - 11/2002
46	Glycemic Control 01/2024 - 11/2005
28	Length of Stay 02/2024 - 12/2002
11	Critical Care (Surgical Intensive Care) 01/2024 - 09/2004
4	Drug Therapy (Chemotherapy) 10/2022 - 11/2010
3	Surgical Amputation (Amputations) 10/2022 - 12/2020
3	Enteral Nutrition (Feeding, Tube) 01/2022 - 04/2009
3	Parenteral Nutrition 02/2013 - 04/2011
3	Intravenous Infusions 04/2010 - 09/2004
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2021 - 01/2017
2	Renal Dialysis (Hemodialysis) 10/2020 - 01/2020
2	Injections 06/2020 - 03/2018
2	Artificial Respiration (Mechanical Ventilation) 01/2020 - 11/2005
2	Long-Term Care 01/2018 - 01/2015
2	Total Parenteral Nutrition 01/2014 - 04/2010